Article Details
Retrieved on: 2024-03-24 15:13:41
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the initiation of clinical trials in India for the Spanish TB vaccine MTBVAC, which Biofabri developed. MTBVAC uses a genetically modified form of Mycobacterium tuberculosis and aims to be more effective than the century-old BCG vaccine.
Article found on: www.thehindu.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here